SERS-based lateral flow assay for simultaneous detection of SCCA and cancer antigen 125 (CA125) in serumDetection limit: 8.093 pg/mL for SCCA and 7.370 pg/mL for CA125SERS intensities at 1083 cm−1 (SCCA) and 1330 cm−1 (CA125) increased in serum from cervical cancer and precancer patients compared to healthy subjectsGood agreement between SCCA and CA125 levels measured by SERS and ELISA in serum samples. The gene discussed is MUC16; the disease is cervical cancer.